Pharmacological adjuncts in the treatment of opiate dependence.
D003496:Cyclazocine / Q000494:pharmacology / Q000627:therapeutic use; D003521:Cyclopropanes / Q000031:analogs & derivatives / Q000494:pharmacology; D004341:Drug Evaluation; D005260:Female; D003932:Heroin / Q000037:antagonists & inhibitors; D006556:Heroin Dependence / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009022:Morphine Derivatives / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D009892:Opium / Q000037:antagonists & inhibitors; D010146:Pain / Q000188:drug therapy; D011680:Pupil / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D019966:Substance-Related Disorders / Q000188:drug therapy*
D003521:Cyclopropanes; D009022:Morphine Derivatives; D009292:Narcotic Antagonists; D009270:Naloxone; D003932:Heroin; D009892:Opium; D003496:Cyclazocine